Acorn Capital Advisors, LLC X4 Pharmaceuticals, Inc Transaction History
Acorn Capital Advisors, LLC
- $144 Billion
- Q1 2025
A detailed history of Acorn Capital Advisors, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 7,310,650 shares of XFOR stock, worth $19.8 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
7,310,650
Previous 7,310,650
-0.0%
Holding current value
$19.8 Million
Previous $5.36 Billion
67.28%
% of portfolio
1.22%
Previous 2.82%
Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
100Shares Held
97.9MCall Options Held
500KPut Options Held
20.4K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$45.8 Million1.36% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$40.6 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.07MShares$21.9 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY7MShares$19 Million0.19% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $186M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...